Inari Medical Inc (NARI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,636 | -29,267 | 9,840 | 13,789 | -1,192 |
| Depreciation Amortization | -2,498 | 7,262 | 4,451 | 1,566 | 729 |
| Income taxes - deferred | -584 | N/A | N/A | N/A | N/A |
| Accounts receivable | -11,054 | -17,030 | -14,361 | -16,706 | -9,017 |
| Accounts payable and accrued liabilities | 344 | 1,140 | 3,514 | 498 | 1,835 |
| Other Working Capital | 2,638 | -21,468 | -14,300 | -21,169 | -6,321 |
| Other Operating Activity | 48,717 | 45,391 | 36,342 | 23,934 | 9,030 |
| Operating Cash Flow | $35,927 | $-13,972 | $25,486 | $1,912 | $-4,936 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,201 | -9,951 | -13,645 | -5,460 | -3,144 |
| Net Acquisitions | -240,419 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -406,738 | -497,865 | -134,377 | -49,977 | N/A |
| Sale Of Investment | 595,340 | 312,600 | 97,000 | 0 | N/A |
| Investing Cash Flow | $-58,018 | $-195,216 | $-51,022 | $-55,437 | $-3,144 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 10,000 | 20,000 |
| Debt Repayment | N/A | N/A | N/A | -30,250 | -10,140 |
| Common Stock Issued | 10,745 | 183,627 | 6,427 | 164,832 | 127 |
| Other Financing Activity | -9,574 | -6,489 | -2,354 | -467 | 236 |
| Financing Cash Flow | $1,171 | $177,138 | $4,073 | $144,115 | $10,223 |
| Exchange Rate Effect | -94 | -480 | -402 | 0 | 0 |
| Beginning Cash Position | 60,222 | 92,752 | 114,617 | 24,027 | 21,884 |
| End Cash Position | 39,208 | 60,222 | 92,752 | 114,617 | 24,027 |
| Net Cash Flow | $-21,014 | $-32,530 | $-21,865 | $90,590 | $2,143 |
| Free Cash Flow | |||||
| Operating Cash Flow | 35,927 | -13,972 | 25,486 | 1,912 | -4,936 |
| Capital Expenditure | -6,201 | -9,951 | -13,645 | -5,460 | -3,144 |
| Free Cash Flow | 29,726 | -23,923 | 11,841 | -3,548 | -8,080 |